Adc Therapeutics
(NYSE) ADCT
Adc Therapeutics Financials at a Glance
Market Cap
$480.23M
Revenue (TTM)
$81.36M
Net Income (TTM)
$142.62M
EPS (TTM)
$-1.20
P/E Ratio
-3.15
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$3.68
Volume
12,905
Open
$3.76
Price
$3.68
Volume
12,905
Open
$3.76
Previous Close
$3.68
Daily Range
$3.67 - $3.83
52-Week Range
$1.05 - $4.98
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$3.68
Volume
12,905
Open
$3.76
Previous Close
$3.68
Daily Range
$3.67 - $3.83
52-Week Range
$1.05 - $4.98
ADCT News
ADCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adc Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
193
CEO
Ameet Mallik, MBA
Website
www.adctherapeutics.comHeadquarters
Epalinges, 1066, CH
ADCT Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-43%
Return on Assets
-44%
Earnings Yield
-31.75%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$480.23M
Shares Outstanding
127.04M
Volume
12.90K
Short Interest
0.00%
Avg. Volume
813.79K
Financials (TTM)
Gross Profit
$73.68M
Operating Income
$108.38M
EBITDA
$106.50M
Operating Cash Flow
$141.17M
Capital Expenditure
$264.00K
Free Cash Flow
$141.44M
Cash & ST Invst.
$261.34M
Total Debt
$439.01M
Adc Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$23.06M
+36.4%
Gross Profit
$19.48M
+25.4%
Gross Margin
84.50%
N/A
Market Cap
$480.23M
N/A
Market Cap/Employee
$1.83M
N/A
Employees
263
N/A
Net Income
$6.41M
+79.1%
EBITDA
$11.81M
+37.3%
Quarterly Fundamentals
Net Cash
$177.67M
-238.9%
Accounts Receivable
$29.12M
+43.3%
Inventory
$4.18M
-77.2%
Long Term Debt
$437.05M
+259.3%
Short Term Debt
$3.00M
+118.8%
Return on Assets
-44.14%
N/A
Return on Invested Capital
-42.84%
N/A
Free Cash Flow
$31.13M
-41.9%
Operating Cash Flow
$31.12M
-42.4%